MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor (Q38321646)

2 September 2017

MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor (English)

1 reference

2 September 2017

X Sastre-Garau

5

0 references

Olivier Delattre

6

object named as

O Delattre

1 reference

2 September 2017

G-A Franzetti

1

1 reference

2 September 2017

K Laud-Duval

2

1 reference

2 September 2017

D Bellanger

3

1 reference

2 September 2017

M-H Stern

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

2 September 2017

1 reference

2 September 2017

32

1 reference

2 September 2017

3915-3921

1 reference

2 September 2017

33

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.403

2 September 2017

0 references

cites work

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Recent advances in the molecular pathogenesis of Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

CD99 signals caspase-independent T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Mesenchymal stem cell features of Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Regulation of mRNA translation and stability by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

miR-29 and miR-30 regulate B-Myb expression during cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNAs in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Characterization of a new brain-specific isoform of the EWS oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

CD99 plays a major role in the migration of monocytes through endothelial junctions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

Production and Characterization of Mouse Monoclonal Antibodies to Wild-Type and Oncogenic FLI-1 Proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.403

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.403

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference